Evidence map›Paper›PMID 34767798›Full record

ArticleThe Journal of biological chemistry2021

A GX

Garima, Rashima Prem, Usha Yadav, Monica Sundd

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

GarimaNMR Lab, National Institute of Immunology, New Delhi, India.
Rashima PremNMR Lab, National Institute of Immunology, New Delhi, India.
Usha YadavNMR Lab, National Institute of Immunology, New Delhi, India.
Monica SunddNMR Lab, National Institute of Immunology, New Delhi, India. Electronic address: monicasundd@nii.ac.in.
National Institute of Immunology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Saccharomyces cerevisiae acyl carrier protein (ScACP) is a component of the large fungal fatty acid synthase I (FAS I) complex. ScACP comprises two subdomains: a conserved ACP domain that shares extensive structural homology with other ACPs and a unique structural domain. Unlike the metazoan type I ACP that does not sequester the acyl chain, ScACP can partially sequester the growing acyl chain within its hydrophobic core by a mechanism that remains elusive. Our studies on the acyl-ScACP intermediates disclose a unique

Indexed as

Acyl Carrier ProteinAmino Acid MotifsNuclear Magnetic Resonance, BiomolecularProtein Conformation, alpha-HelicalSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAcyl Carrier ProteinSaccharomyces cerevisiae Proteinsacyl-ACP interactionacyl carrier proteinacyl chain sequestrationchemical shift perturbationsfatty acid biosynthesisNMRS. cerevisiae ACPtype I ACPtype I FAS

Identifiers

PMID34767798
PMCPMC8683515
OpenAlexW3214199888

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.